Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.86
Delayed Data
As of 12:31pm ET
 +0.21 / +12.73%
Today’s Change
1.48
Today|||52-Week Range
5.00
-6.06%
Year-to-Date

Today’s Trading

Previous close1.65
Today’s open1.52
Day’s range1.49 - 1.86
Volume4,704
Average volume (3 months)3,020
Market cap$19.6M
Dividend yield--
Data as of 12:31pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+1.68%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book4.09

Competitors

 Today’s
change
Today’s
% change
EVOKEvoke Pharma Inc-0.10-2.90%
ATOSAtossa Genetics Inc+0.04+5.26%
BVXVBiondVax Pharmaceuti...+0.56+16.05%
NUINNutrastar Internatio...-0.12-17.00%
Data as of 3:52pm ET, 09/02/2015

Financials

Next reporting dateDecember 2, 2015
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$0.00
Annual profit (last year)-$2.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts

Partner Offers